Think Research Corporation announces a $5 million contract expansion

Think Research Corporation, based in Toronto and listed on the TSXV under the ticker symbol "THNK", has recently announced an expanded contractual scope with a long-standing global pharmaceutical client. This expansion represents an addition of $5 million to the initial contract, bringing the total contract value to approximately $15 million since May 2022. The expanded agreement includes new exclusive learning modules and an annual SaaS license for Think's Learning Management System (LMS), already deployed during 2022 and 2023.

Think Research CEO, Sachin Aggarwal, expressed satisfaction with the ongoing value that the company's LMS brings to its global clients. He emphasized the importance of their platform in providing essential data, services, and solutions to clinicians. Think Research is positioning itself as a valuable partner in the digital health sector.

Think Research Corporation specializes in knowledge-based software solutions and data for the healthcare sector. With a wide range of solutions that facilitate clinical decision-making, access to services, and standardization of care, Think Research aims to improve outcomes in the healthcare field.